Table 4.
Comparisons of genotype frequencies in AITD patients and controls.
| SNP ID | Allele/genotype frequency n (%) | P value [OR (95% CI)] | ||||||
|---|---|---|---|---|---|---|---|---|
| Control | AITD | GD | HT | AITDs vs. C | GD vs. C | HT vs. C | ||
| rs6568431 | AA | 67 (8.7) | 88 (10.7) | 59 (10.7) | 29 (10.7) | 0.200 [1.244 (0.890-1.737)] | 0.247 [1.242 (0.860-1.796)] | 0.346 [1.247 (0.787-1.974)] |
| AC+CC | 697 (91.3) | 736 (89.3) | 494 (89.3) | 242 (89.3) | Reference | Reference | Reference | |
|
| ||||||||
| rs548234 | CC | 53 (6.9) | 65 (7.9) | 43 (7.8) | 21 (7.7) | 0.474 [1.147 (0.787-1.673)] | 0.563[1.131 (0.745-1.718)] | 0.656 [1.127 (0.666-1.906)] |
| CT+TT | 711 (93.1) | 760 (92.1) | 510 (92.2) | 250 (92.3) | Reference | Reference | Reference | |
|
| ||||||||
| rs6937876 | GG | 70 (9.2) | 89 (10.8) | 61 (11.0) | 28 (10.3) | 0.277 [1.201 (0.863-1.670)] | 0.263 [1.229 (0.856-1.766)] | 0.572 [1.142 (0.720-1.813)] |
| AG+AA | 694 (90.8) | 735 (89.2) | 492 (89.0) | 243 (89.7) | Reference | Reference | Reference | |